Take it to the Crowd

Anne Wojcicki, co-founder and CEO of 23andMe, spoke at Harvard University about crowdsourcing science, reports The Wall Street Journal's Health Blog. Wojcicki said that relying on the crowd can get researchers answers more quickly. For example, she described 23andMe researchers sending out a survey on family history of cancer to customers in their database with mutations linked to cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.